1Dalainas I. Pathogenesis,diag~osis,and management of disseminated intravascular coagulation :a literature review [ J ]. Eur Rev Med Pharmacol Sci,2008,12 ( 1 ) : 19 - 31.
2Taylor JR FB, Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation - on behalf of the Scientific Subcommittee on disseminated intravascular coagulation (DIC)of the Interna- tional Society on Thrombosis and Haemostasis(ISTH) [ J]. Thromb Haemost ,2001,86 : 1327 - 1230.
3Levi M, Ten CH. Disseminated intravascular coagulation [ J]. N Engl J Med,1999,341:586 -592.
4Bernard GR, Vincent JL, Laterre PF, et al. Recombinant human Protein C worldwide evaluation in severe sepsis(PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis [ J ]. N Engl J Med ,2001,344:699 -709.
5Abraham E, Laterre PF, Garg R, et al. Administration of drotrecogin Alfa ( activated ) in early stage severe sepsis ( address ) study group. Drotrecogin alfa(activated) for adults with severe sepsis and a low risk of death[J]. N Engl J Med,2005 ,353 :1332 - 1341.
6Kessler CM, Tang Z, Jacobs HM, et al. The suprapharmacological dosing of antithrombin concentrate for Staphylococcus aureus induced disseminated intravascular coagulation in guinea pigs:substantial reduction in mortality and morbidity[ J]. Blood, 1997,89: 4393 - 4401.
7Elsayyed YA, Nakagawa K, Kamikubo YI, et al. Effects of recombinant human tissue factor pathway inhibitor on thrombus formation and its in vivo distribution in a rat DIC model [ J ]. Am J Clin Pathol, 1996,106:574 - 583.
8Abraham E, Reinhart K, Opal S, et al. Optimist Trial Study Group. Efficacy and safety of tifacogin ( recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial [ J]. JAMA,2003,290 : 238 - 247.
9Fujita M, Izutani W, Komurasaki Y. Effect of urinary protein C inhibitor on lipopolysaccharide-induced disseminated intravascular coagulation in rats[ J]. Thromb Haemost,2000,84 ( 1 ) :54 - 58.
10Moscardo F,Perez F,De La RJ,et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VK [ J ]. Br J Haemato1,2001,114 ( 1 ) : 174 - 176.
10Dalainas I. Pathogenesis diagnosis and management of disseminated intravascular coagulation: a literature review [J]. Eur Rev Med Phamacol Sci,2008,12(1) :19.
